medigraphic.com

2009, Number S1

<< Back Next >>

Rev Mex Anest 2009; 32 (S1)

Perioperative heart failure

Luna-Ortíz P

Language: Spanish
References: 18
Page: 60-64
PDF size: 74.06 Kb.


Text Extraction

No abstract


REFERENCES

  1. McMurray JV, Pfeffer MA. Heart failure. Lancet 2005;365:1877-1889.

  2. Jessup M, Arozena S. Heart failure. N Engl J Med 2003;348:2007-2018.

  3. Aronow WS, Ahn C, Kronzon I, Koenigsberg M. Congestive heart failure, coronary events and atherothrombotic brain infarction in elderly blacks and whites with systemic hypertension and with and without echocardiographic and electrocardiographic evidence of left ventricular hypertrophy. Am J Cardiol 1991;67:295-299.

  4. Aronow W, Ahn C, Kronzon I. Comparison of incidences of congestive heart failure in older African-Americans, Hispanics and whites. Am J Cardiol 1999;84:611-612.

  5. Aronow W. Effects of aging on the heart. In: Tallis H, Broccklehurst J, eds. Brocklehurst’s Textbook of Geriatric medicine and Gerontology. Edinburgh: Churchill Livingstone, 1998:255-262.

  6. Aronow WS. Epidemiology, pathophysiology, prognosis and treatment of systolic and diastolic Heart failure in elderly patients. Herat Dis 2003;5:279-294.

  7. Cohn JN, Levine TB, Olivari MT. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med 1984;311:819-823.

  8. Mason DT. Congestive heart failure, mechanisms, evaluation and treatment. York Med Books, New York, 1976. p. 1.

  9. Guadalajara BJF. Entendiendo la insuficiencia cardíaca. Arch Cardiol Mex 2006;76:431-447.

  10. Brandt RR, Whright S, Redfield MM. Atrial natriuretic peptide in heart failures. J Am Coll Cardiol 1993;22(suppl A):86A-92A.

  11. Weber KT, Janichy JS. The heart failure. Am Heart J 1979;98:371-384.

  12. Golberg LR, Jessup M. Stage B, Heart failure management of asymptomatic left ventricular systolic dysfunction. Circulation 2006;113:2851-2860.

  13. Mahler F, Yoran C, Ross JRJ. Inotropic effect of tachycardia and poststimulation in the consciencius dog. Am J Physiol 1974;227:569-575.

  14. Dzau VJ, Colucci WS, Hollemberg NK, William GH. Relation of the rennin-angiotensin-aldosterone system to clinical state in congestive heart failure. Circulation 1981;63:645-651.

  15. Grossman W. Cardiac hypertrophy: useful adaptation or pathologic process. Am J Med 1980;69:576-584.

  16. Thiedemann KU, Holeibarsch C, Mediegorac I, Jacob R. Connective tissue content and myocardial stiffness in pressure overload hypertrophy: A combined study of morphologic, morphometric, biochemical and mechanical parameters. Basic Res Cardiol 1983;78:140-155.

  17. Lupi-Herrera E, Chuquiure E, González H, Cuéllar BM, Arias A, Martínez C. El poder cardíaco un instrumento del pasado, posiblemente una herramienta moderna en la valoración: clínica, terapéutica y pronóstica del choque cardiogénico por síndrome isquémico coronario agudo.

  18. Méndez A. Fisiopatología de la insuficiencia cardíaca. Arch Cardiol Mex 2006;76:S2,182-187.




2020     |     www.medigraphic.com